Home >  Registry
     
 
Protocol Registry Trial Results IFPMA Background Links
About this Registry

This registry serves as a global repository for information on ongoing Roche Pharmaceuticals Phase II to Phase IV clinical studies, Phase I studies in patients and Roche Diagnostics interventional studies on advanced diagnostic products.

For More Information 

Common Questions
More Frequently Asked Questions 
Overview of Clinical Trials 
Glossary of Terms 
Phase Definitions 
Field Definitions 
Roche Clinical Trial Global Policy 
Site Provided by Thomson CenterWatch

Myelogenous Leukemia, Chronic

Click on a country name to search for Myelogenous Leukemia, Chronic trials by location.



Austria

Bulgaria

Canada

China

Czech Republic

France

Germany

Hungary

India

Israel

Italy

Mexico

Poland

Russian Federation

Slovakia

South Africa

Spain

Taiwan

Thailand

United Kingdom

United States